Over +8 years, I've participated in more than 30 clinical trials involving Phase II,III and IV clinical studies.I am ultimately responsible for the successful management of investigator sites throughout the site life cycle, whilst working in accordance with ICH-GCP guidelines, the study protocol, applicable local and international regulatory requirements and internal Standard Operating Procedures. In addition to planning and conducting various site visits (feasibility, site selection, monitoring and close-out visit) in accordance with the clinical monitoring plan.